A new collaboration between Bristol-Myers Squibb and the California Institute for Biomedical Research (Calibr) was announced today.
Articles by Isaura Santos
Corbus Pharmaceuticals Holdings, Inc. is an emerging drug development company focused on the development and commercialization of…
New research presented at the American College of Rheumatology’s Annual Meeting in Boston claims that end-stage…
November 18th has been officially named chronic thromboembolic pulmonary hypertension (CTEPH) Awareness Day. This will be the first ever…
A live webinar exploring the development of Pulmonary Fibrosis in Scleroderma patients will be hosted by Dr. Paul Wolters, Director…
ProMetic Life Sciences Inc. is currently preparing an Orphan Drug Designation (ODD) request for the company’s novel Idiopathic Pulmonary…
The Pulmonary Fibrosis Foundation (PFF) applauded the recent news that both Esbriet® (pirfenidone) and Ofev® (nintedanib) were approved by…
The 6th Annual North Carolina Research Triangle Pulmonary Hypertension Symposium will be held on November 7th at the DoubleTree…